Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001831:Body Temperature; D003168:Complement Fixation Tests; D004890:Erythema / Q000209:etiology; D005334:Fever / Q000209:etiology; D006168:Guinea Pigs; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007106:Immune Sera; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D009975:Orthomyxoviridae / Q000276:immunology; D011817:Rabbits; D014611:Vaccination; D014765:Viral Vaccines / Q000009:adverse effects
D000906:Antibodies; D006389:Hemagglutinins, Viral; D007106:Immune Sera; D007252:Influenza Vaccines; D014765:Viral Vaccines